Philips HEARTSTART XLT M3500B Manuale Utente

Pagina di 180
Clinical Performance Summary - Defibrillation
13-14
Specifications & Safety
Clinical Performance Summary - Defibrillation
An international, multicenter, prospective, randomized, clinical study was 
conducted to assess the effectiveness of the SMART Biphasic waveform in 
out-of-hospital sudden cardiac arrests (SCAs), as compared to monophasic 
waveforms. The primary objective of the study was to compare the percent of 
patients with ventricular fibrillation (VF) as the initial monitored rhythm that 
were defibrillated in the first series of three shocks or less. 
This section summarizes the methods and results of this study.
Methods
Victims of out-of-hospital SCA were prospectively enrolled in four emer-
gency medical service (EMS) systems. Responders used either 150J SMART 
Biphasic AEDs or 200-360J monophasic waveform AEDs. A sequence of up 
to three defibrillation shocks were delivered. For the biphasic AEDs, there 
was a single energy output of 150J for all shocks. For monophasic AEDs, the 
shock sequence was 200, 200, 360J. Defibrillation was defined as termination 
of VF for at least five seconds, without regard to hemodynamic factors.
Results
Randomization to the use of monophasic or SMART Biphasic automatic 
external defibrillators (AEDs) was done in 338 SCAs from four emergency 
medical service systems. VF was observed as the first monitored rhythm in 
115 patients. The biphasic and monophasic groups for these 115 patients were 
similar in terms of age, sex, weight, primary structural heart disease, cause or 
location of arrest, and bystanders witnessing the arrest or performing CPR.
The 150J SMART Biphasic waveform defibrillated 98% of VF patients in the 
first series of three shocks or less, compared with 69% of patients treated with 
monophasic waveform shocks. Outcomes are summarized in Table 13-3.